$TLSI Balance Sheet | Understand Stock

$TLSI

$3.80 +$0.18 (4.97%) Close

$TLSI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Current assets
Cash and cash equivalents
Accounts receivable (net of allowance of $98 and $24, respectively)
Inventory, net
Prepaid expenses
Total current assets
Cash and investments held in Trust Account
Property and equipment, net
Right-of-use assets
Intangible assets, net
Other assets
Total assets

Liabilities and Stockholders’ Equity (Deficit)
Liabilities
Current liabilities
Accounts payable and accrued expenses
Due to stockholders
Trade payables
Accrued liabilities
Derivative liability, current
Series B-2 tranche liabilities
Series B-3 warrant liabilities

Short-term lease liabilities
Other current liabilities
Income taxes payable
Extension Note
Convertible Promissory Note - related party
Promissory note - related party
Total current liabilities

Convertible note - related party
Convertible Promissory Note - related party
Deferred underwriting fee payable
Long-term debt
Revenue base redemption liability
Long-term lease liabilities
Contingent earnout liability
Warrant liabilities
Contingent earnout liability
Warrant liability
Total warrant liabilities
Total liabilities
Convertible Preferred Stock
Class A common stock subject to possible redemption
Total convertible Preferred Stock

Stockholders’ equity (deficit)
Preferred Stock, $0.0001 par value, 10,000,000 shares authorized; 0 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Common stock, $0.0001 par value, 400,000,000 shares authorized at June 30, 2026 and December 31, 2025, respectively; 61,469,572 shares and 49,997,836 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Class A Common Stock
Class B Common Stock
Total common stock, $0.0001 par value, 400,000,000 shares authorized at June 30, 2026 and December 31, 2025, respectively; 61,469,572 shares and 49,997,836 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively

Additional paid-in capital
Accumulated deficit
Total stockholders’ equity (deficit)
Total liabilities and stockholders’ equity (deficit)

Comments